SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Markvicka Taunia

(Last) (First) (Middle)
C/O PACIRA PHARMACEUTICALS, INC.
5 SYLVAN WAY, SUITE 100

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/21/2012
3. Issuer Name and Ticker or Trading Symbol
Pacira Pharmaceuticals, Inc. [ PCRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President, Commercial
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (1) 09/01/2020 Common Stock 21,385 1.61 D
Employee Stock Option (right to buy) (2) 09/01/2020 Common Stock 29,754 1.61 D
Employee Stock Option (right to buy) (3) 12/28/2020 Common Stock 18,349 5.49 D
Explanation of Responses:
1. The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the Vesting Commencement Date of September 2, 2010; 1/36th of the shares shall vest over the three year period thereafter.
2. The stock option vests as follows: 50% of the shares are vested upon the date of grant; 50% of the remaining shares shall vest in monthly installments over the next 24 months.
3. The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the Vesting Commencement Date of December 29, 2010; 1/36th of the shares shall vest over the three year period thereafter.
/s/ Taunia Markvicka 03/29/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.